Anderson Hoagland Co Lowers stake in CVS Health Corp (CVS)

CVS Health Corp (CVS) : Anderson Hoagland Co reduced its stake in CVS Health Corp by 18.45% during the most recent quarter end. The investment management company now holds a total of 28,775 shares of CVS Health Corp which is valued at $2,791,175 after selling 6,510 shares in CVS Health Corp , the firm said in a disclosure report filed with the SEC on Jul 18, 2016.CVS Health Corp makes up approximately 1.71% of Anderson Hoagland Co’s portfolio.

Other Hedge Funds, Including , Cribstone Capital Management boosted its stake in CVS in the latest quarter, The investment management firm added 503 additional shares and now holds a total of 17,907 shares of CVS Health Corp which is valued at $1,736,979. CVS Health Corp makes up approx 1.08% of Cribstone Capital Management’s portfolio.Btr Capital Management Inc boosted its stake in CVS in the latest quarter, The investment management firm added 35,920 additional shares and now holds a total of 139,792 shares of CVS Health Corp which is valued at $13,541,651. CVS Health Corp makes up approx 3.01% of Btr Capital Management Inc’s portfolio.Davis R M Inc boosted its stake in CVS in the latest quarter, The investment management firm added 2,273 additional shares and now holds a total of 10,390 shares of CVS Health Corp which is valued at $1,006,479. CVS Health Corp makes up approx 0.05% of Davis R M Inc’s portfolio.Factory Mutual Insurance Co boosted its stake in CVS in the latest quarter, The investment management firm added 30,000 additional shares and now holds a total of 1,293,000 shares of CVS Health Corp which is valued at $126,235,590. CVS Health Corp makes up approx 1.62% of Factory Mutual Insurance Co’s portfolio.

CVS Health Corp opened for trading at $97.26 and hit $97.37 on the upside on Wednesday, eventually ending the session at $97, with a gain of 0.10% or 0.1 points. The heightened volatility saw the trading volume jump to 34,85,961 shares. Company has a market cap of $104,180 M.

On the company’s financial health, CVS Health Corp reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on May 3, 2016. Analyst had a consensus of $1.16. The company had revenue of $43215.00 million for the quarter, compared to analysts expectations of $43000.77 million. The company’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.

Many Wall Street Analysts have commented on CVS Health Corp. Shares were Reiterated by Mizuho on Jun 23, 2016 to “Buy” and Lowered the Price Target to $ 108 from a previous price target of $117 .Shares were Reiterated by Deutsche Bank on Jun 22, 2016 to “Hold” and Lowered the Price Target to $ 99 from a previous price target of $105 .CVS Health Corp was Downgraded by Morgan Stanley to ” Equal-Weight” on Jun 20, 2016.

CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *